AstraZeneca CEO Pascal Soriot and Prince Charles at the official opening of the pharma's new global research and development facility at the Cambridge Biomedical Campus (Chris Jackson/Getty Images)

June 2, 2022 06:53 AM EDT

Pascal Soriot's big year at the helm of AstraZeneca is crowned with a knighthood

John Carroll

Editor & Founder

Pascal Soriot’s victory lap leading up to his 10th anniversary as CEO of a radically transformed AstraZeneca comes with a knighthood.

Soriot — born and raised …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Pascal Soriot's big year at the helm of AstraZeneca is crowned with a knighthood

John Carroll

Editor & Founder

Sign up to read this article for free.

Bicycle Therapeutics stock sinks following release of topline data, post-hoc analyses

AbbVie makes another small I&I acquisition, buying Nimble for $200M

McKinsey hit with a $650M fine for deceiving US about opioid consulting work

EMA's committee says expanded label for Lilly's Mounjaro into sleep apnea not necessary

Gilead names Dietmar Berger CMO as it eyes R&D reset

Xaira hires former Roche exec as CMO; 'Tis the season for retirements at Alnylam, Regeneron

Pas­cal So­ri­ot's big year at the helm of As­traZeneca is crowned with a knight­hood

John Carroll

Editor & Founder

Sign up to read this article for free.

more like this

Bi­cy­cle Ther­a­peu­tics stock sinks fol­low­ing re­lease of topline da­ta, post-hoc analy­ses

Ab­b­Vie makes an­oth­er small I&I ac­qui­si­tion, buy­ing Nim­ble for $200M

McK­in­sey hit with a $650M fine for de­ceiv­ing US about opi­oid con­sult­ing work

EMA's com­mit­tee says ex­pand­ed la­bel for Lil­ly's Moun­jaro in­to sleep ap­nea not nec­es­sary

Gilead names Di­et­mar Berg­er CMO as it eyes R&D re­set

Xaira hires for­mer Roche ex­ec as CMO; 'Tis the sea­son for re­tire­ments at Al­ny­lam, Re­gen­eron

Pascal Soriot's big year at the helm of AstraZeneca is crowned with a knighthood

Bicycle Therapeutics stock sinks following release of topline data, post-hoc analyses

AbbVie makes another small I&I acquisition, buying Nimble for $200M

McKinsey hit with a $650M fine for deceiving US about opioid consulting work

EMA's committee says expanded label for Lilly's Mounjaro into sleep apnea not necessary

Gilead names Dietmar Berger CMO as it eyes R&D reset

Xaira hires former Roche exec as CMO; 'Tis the season for retirements at Alnylam, Regeneron